Smacc

Gerrie gives a fantastic 7 min intro into how to decipher a CT brain.

Clinical trials are expensive and take years to go. Do they generate patient and economic benefit that justifies the cost of trials?

Bec Nogajski takes you on a 20-minute journey about YOU. How your team, how you follow, and what leadership style would work for you.

Evie Marcolini talks about an aspect of neurocritical care that we commonly wrestle with: prognostication. Putting the patient at the centre of all conversations is essential. For more head to: codachange.org/podcasts

How can something that makes so much sense physiologically not have any positive trial outcomes? Are we disrupting an important potentially beneficial cellular function by our current processes and timing of cooling? Is it targeted hypothermia or is it therapeutic? Will the TTM2 shed any further light and lead to practice change? All these questions and more will be answered in a snap-shot talk of what is (at least!) a decade-long debate, filled with numerous high-quality studies. For more head to: codachange.org/podcasts

Everyone has the potential to live a creative life - As healthcare professionals, how might we do so? In this talk Grace Leo chats about what creativity is and what it might look like in various areas of our lives. She also interviews Hugh Montgomery; a climate change advocate, story book author and Guinness world record holder for playing the piano underwater.

This presentation will give you an update of the current chest pain protocols; including risk scores (HEART, TIMI, EDACS) with / without high sensitive troponin. But also on the newer pathways with rule out of acute coronary syndrome with a high sensitive troponin below the limit of detection or two troponins with a delta. How do we use these chest pain protocols in tomorrow’s clinical practice? How do you choose a protocol that fits in your institution? Which chest pain patient can we discharge safely from the emergency department and for whom should we organize outpatient follow up? And how do you share your decision with the patient in front of you.

Andrew Dixon from Radiopaedia goes through 5 classic fails - common misses in trauma imaging. Learn from this rather than missing them yourself! See if you can spot the pathology before Andrew explains it to you - you can scroll through the scans on Radiopaedia here: https://radiopaedia.org/playlists/1976c00393ca4c9d9878566c3487d97a?lang=gb

Sexual assault affects 1 in 3 women and 1 in 6 men during their lifetime worldwide. It is more common than most medical issues we are trained to look for, despite this being a patient population we are going to see by virtue of the "anyone, anytime" nature of an emergency and critical care. Generous estimates find than only 20% of survivors present for medical care and may not disclose this initially in their visit. Look for it during public holidays, large parties or concerts, college or university frosh week, particularly in young women. Other scene awareness clues that a sexual assault may have occurred include sedation that does not match the substances taken or clinical level seen, ripped or missing clothing, or being separated from their group. Documenting your suspicions and findings is key - as this chart is more likely to go to court, but not for 2 years. Direct quotations of what was said by the patient or EMS, body diagrams for what was found, and your clinical decision making are the essentials.

The rising death toll from our nation‚ opioid epidemic has been rivaled in modern history only by that at the peak of the AIDS epidemic in the early 1990s. Consider, in 1995 at the peak of the AIDS epidemic, 51,000 Americans died from the disease. In 2015, 52,000 died from drug overdoses. Emergency departments have stood at the front lines of both crises. As a specialty that prides itself on rising to the occasion at times of great need, our time to lead on this crisis is now. As a response, EDs nationwide are expanding their roles in the care of patients with opioid use disorder (OUD), and many have begun ED-MAT programs. In December of 2017, we launched the Get Waivered Campaign which aimed to get our physicians the DEA X waivers needed to be able to prescribe ED-MAT(buprenorphine) to patients coming to our hospital seeking recovery. In May of 2018, our ED instituted its first ED-MAT protocol and while greater than 90% of our attending physicians had their DEA-X waivers and were able to prescribe buprenorph

A case example of a large vessel obstruction of the brain and our current techniques available to treat it. How we make decisions on endovascular treatment and management points for emergency and intensive care colleagues.

This talks gives some guidance on how to deal with your anxiety and fear when dealing with children. We will also cover some keytopic areas: sepsis, fluids, seizures, asthma and bronchiolitis

in March 2006, six healthy volunteers underwent cytokine-induced injury and multiorgan failure from a Phase 1 first-in-human drug trial with a novel monoclonal antibody. This talk describes the clinical and incident management ramifications, drawing connections to other non-conventional incidents which may pose a different pattern of clinical, operational and communications challenges to the 'classic' trauma-based model of major incidents.

This talk will introduce the audience to the dynamics and effects of childhood abuse from a human rights framework. It will explore pertinent aspects of recovery and illuminate the healing possibilities that exist within every relationship between a child and any adult professional.

Resuscitation fluids save lives in humans with life-threatening hypovolaemia. The fluid of choice should have biochemical characteristics close to the type of fluid lost and replaced at a rate and volume sufficient to correct the severe fluid deficit. Then stop and consider the early use of catecholamines. There are few indications to give critically ill patients resuscitation fluids after 24 hours of admission. There is no place for synthetic colloids of non-physiological crystalloids. The effects of unnecessary fluids last well beyond the initial resuscitation period and are associated with adverse effects and harm to the patient. Fluids are toxic drugs and must be used with great care.

I am part of the opening panel.